Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki Disease
Latest Information Update: 06 Mar 2024
At a glance
- Drugs Anakinra (Primary) ; Anakinra (Primary)
- Indications Mucocutaneous lymph node syndrome
- Focus Adverse reactions
- 27 Mar 2023 Status changed from active, no longer recruiting to completed.
- 01 Mar 2022 Planned End Date changed from 1 Dec 2021 to 1 Dec 2022.
- 01 Mar 2022 Planned primary completion date changed from 1 Oct 2021 to 1 Oct 2022.